XBIT..18.00 FDA gave go-ahead for XBiotech's candidate therapy for Phase 1/2 double-blindplacebo controlled study in pancreatic cancer Float 17.61 million Assets 354 million Debt 0 Cash Covers Cash Burn Short term assets exceeds Short and Long term liabilities Revenue growth 84% per year
ARTL..Up 12% pre-market..1.30 Bio-pharm Cannaboid Therapy Assets 13 million Debt 0 TipRanks Moderate Buy Target price 6.00
PTN..Up 11% pre-market...60 Healthcare Assets 86 million Debt 1 million TipRanks Strong Buy with Target price 2.33
Watch List CIDM..Cinedigm..1.23 Leader at the forefront of the digital transformation of content distribution Assets 92 million Debt 25 million TipRanks Moderate Buy Target price 3.25 Barchart Buy
Seeing Green Despite Red Day BMIX...0132..Announced this morning that its iron-focused 60%-owned subsidiary has begun drilling in wholly owned project located in the well-known Iron Quadrangle area of the State of Minar Gerais in Brazil, one of the world's most prolific areas of iron mining. PLYZ...002..Up today of 122% Yesterday announced agreement with Microsoft Dynamics 365 GTEH..Up 27%...0023 Purchased new product line and also has possibly reached bottom.
FSR..12.84 Bank Of America initiated coverage on Fisker with a Strong Buy with a Target Price of 31.00 Analysts said Company standing out among EV competitors Fisker will start production of its new all-electric Ocean SUV by end of 2022
Ones to watch rest of week NGTF...4050 Nightfood announced this morning Walmart distribution from coast to coast over 1,000 stores with its Nightfood ice cream GWHP...69 Global Wholehealth Partners now have the means to identify and test for Dementia using a micro reader or Lateral Flow Test to measure brain enzymes IQST...67 Highlighted Q1 Balance Sheet On Road to Nasdaq Up List With 13.9 million in Revenue and 2 million in Cash
Bounce Back Wednesday SWRM Down 32% .0141 LTNC Down 17% .0435 WTII Down 21% .0100 TSOI Down 19% .0399 RMSL Down 21% .0191 BAOS Down 25% 4.21
Upgraded To Buy ONCT..5.75 Oncternal Therapeutics..Clinical-Stage Oncology Company Undervalued Assets 118 million Debt 40K Float 44 million Cash Covers Cash Burn Short term assets exceeds both Short and Long term liabilities Projected to grow 20% over next three months 6.93-11.61 Revenue to grow 57% over next year TipRanks Strong Buy with Target Price 15.50
With Increased Legalization Of Cannabis HRVSF..Harvest Health and Recreation..2.85 Multi-State Operator Increased Revenue 100% from 2019-2020...231 million Assets 856 million Debt 357 million TipRanks Moderate Buy with Target price 5.73 FFNTF..4Front Ventures..1.26 Has over 25 brands Long term licensing deals worth 650million and 250 million Grew 60% year to year Assets 204 million Debt 120 million
News This Morning GLUC...Glucose Health..2.88 March Revenue Triples At Amazon Glucose health is a manufacturer of dietary supplements to help maintain healthy blood sugar, triglycerides and cholesterol and digestive health Very Low Float 3.86 million
SRNE..Sorrento..Up 4% 7.73 Yesterday announced Sorrento's Human Derived Mesenehymal Stem Cells Achieved 100% Discharge Rate in Critically-ill Covid-19 Patients.
Heavy Insider Buying PHX..2.30..PHX Minerals Oil and Gas Minerals Company Independent Director just bought 52% more shares Assets 97 million Debt 28 million Low Float 12.67 million
PLYZ...0028 Shares of Plyzer Technologies soared 100% yesterday when investors announced it had a deal with Microsoft Dynamics 365 point of sale systems..Plyzer will be providing real-time A1 consumer analytics..payments..and inventory availablity to Microsoft Dynamics 365 Customers.
AITX...075 Robotic Assistance Devices Receives Opening Order from Recently Signed Dealer St. Moritz Security Services
On The Rise Buys ADMA..Biologics..1.72 Developes and commercializes bloodplasma derived products that can be used to treat infectious disease and more importantly help prevent diseases in the first place. 44% year over year increase in Revenue. TipRanks Strong Buy with Target Price 7.67 CBIO..Catalyst Biosciences...4.90 Researches unmet needs in rare disorders of the complement and coagulation systems Float 26 million TipRanks Strong Buy with Target Price 18.50
